Clinical Implications of Measuring Drug and Anti-Drug Antibodies by Different Assays When Optimizing Infliximab Treatment Failure in Crohn's Disease: Post Hoc Analysis of a Randomized Controlled Trial

Casper Steenholdt,Klaus Bendtzen,Jørn Brynskov,Ole C. Thomsen,Mark A Ainsworth

Clinical Implications of Measuring Drug and Anti-Drug Antibodies by Different Assays When Optimizing Infliximab Treatment Failure in Crohn's Disease: Post Hoc Analysis of a Randomized Controlled Trial

2014

Casper Steenholdt
Klaus Bendtzen
Jørn Brynskov
Ole C. Thomsen
Mark A Ainsworth

Clinical Implications of Measuring Drug and Anti-Drug Antibodies by Different Assays When Optimizing Infliximab Treatment Failure in Crohn's Disease: Post Hoc Analysis of a Randomized Controlled Trial

Keywords:

Drug
Randomized controlled trial
Infliximab
Disease
Crohn's disease
Post-hoc analysis
Physical therapy
Medicine
Internal medicine
Gastroenterology
General surgery
Diabetes mellitus
Antibody

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

106

Citations